ezogabine has been researched along with Blood Pressure, High in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fretwell, LV; Woolard, J | 1 |
Chadha, PS; Cockerill, GW; Davis, AJ; Greenwood, IA; Hansen, RS; Harhun, MI; Jepps, TA; Olesen, SP | 1 |
Greenwood, IA; Jepps, TA; Olesen, SP | 1 |
1 review(s) available for ezogabine and Blood Pressure, High
Article | Year |
---|---|
One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders.
Topics: Animals; Anticonvulsants; Carbamates; Constipation; Female; Humans; Hypertension; KCNQ1 Potassium Channel; Membrane Potentials; Membrane Transport Modulators; Muscle Tonus; Muscle, Smooth; Muscle, Smooth, Vascular; Muscular Diseases; Neurons; Obstetric Labor, Premature; Phenylenediamines; Potassium Channels, Voltage-Gated; Pregnancy; Urinary Bladder Diseases | 2013 |
2 other study(ies) available for ezogabine and Blood Pressure, High
Article | Year |
---|---|
Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Carbamates; CHO Cells; Coronary Circulation; Cricetulus; Dose-Response Relationship, Drug; Humans; Hypertension; KCNQ Potassium Channels; KCNQ2 Potassium Channel; Male; Membrane Transport Modulators; Phenylenediamines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Recombinant Proteins; Vasodilation | 2013 |
Downregulation of Kv7.4 channel activity in primary and secondary hypertension.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Carbamates; Down-Regulation; Hypertension; In Vitro Techniques; Indoles; KCNQ Potassium Channels; Male; Membrane Potentials; Mesenteric Arteries; Mice; Phenylenediamines; Rats; Rats, Inbred SHR; Rats, Wistar; Vasoconstrictor Agents | 2011 |